Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J.L. Heerspink, Rey Isidto, Peter Rossing et al.|Nephrology Dialysis Transplantation|2019Cited by 216
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C. Wheeler, Hiddo J.L. Heerspink, Bergur V. Stefánsson et al.|Nephrology Dialysis Transplantation|2020Cited by 189
Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidneyMasahito Ozeki, Naoki Kashihara|The Journal of Physiological Sciences|2009Cited by 21
Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome ActivationYoshihisa Wada, Naoki Kashihara|International Journal of Molecular Sciences|2021Cited by 7